Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis

[1] Henry NL(2016)Role of patient and disease factors in adjuvant systemic therapy decision making for early-stage, operable breast cancer: American society of clinical oncology endorsement of cancer care Ontario guideline recommendations J Clin Oncol 34 2303-2311

[2] Somerfield MR(2014)Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients Psycho-Oncology 23 1103-1110

[3] Abramson VG(2004)Cancer and stigma: experience of patients with chemotherapy-induced alopecia Patient Educ Couns 52 333-339

[4] Choi EK(2008)Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review Psycho-Oncology 17 317-328

[5] Kim I-R(2009)Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations Support Care Cancer 17 181-189

[6] Chang O(2016)General and plastic surgery devices; classification of the scalp cooling system to reduce the likelihood of chemotherapy-induced alopecia. Food and Drug Administration, HHS Fed Regist 81 7452-7454

[7] Rosman S(2005)Prevention of chemotherapy-induced hair loss by scalp cooling Ann Oncol 16 352-358

[8] Lemieux J(2009)Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling Breast Cancer Res Treat 118 547-552

[9] Maunsell E(2010)[Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur Ned Tijdschr Geneeskd 154 A2134-1004

[10] Provencher L(2013)Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer The Breast 22 1001-53

[1] Henry NL(2016)Role of patient and disease factors in adjuvant systemic therapy decision making for early-stage, operable breast cancer: American society of clinical oncology endorsement of cancer care Ontario guideline recommendations J Clin Oncol 34 2303-2311

[2] Somerfield MR(2014)Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients Psycho-Oncology 23 1103-1110

[3] Abramson VG(2004)Cancer and stigma: experience of patients with chemotherapy-induced alopecia Patient Educ Couns 52 333-339

[4] Choi EK(2008)Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review Psycho-Oncology 17 317-328

[5] Kim I-R(2009)Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations Support Care Cancer 17 181-189

[6] Chang O(2016)General and plastic surgery devices; classification of the scalp cooling system to reduce the likelihood of chemotherapy-induced alopecia. Food and Drug Administration, HHS Fed Regist 81 7452-7454

[7] Rosman S(2005)Prevention of chemotherapy-induced hair loss by scalp cooling Ann Oncol 16 352-358

[8] Lemieux J(2009)Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling Breast Cancer Res Treat 118 547-552

[9] Maunsell E(2010)[Allow scalp cooling during adjuvant chemotherapy in patients with breast cancer; scalp metastases rarely occur Ned Tijdschr Geneeskd 154 A2134-1004

[10] Provencher L(2013)Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer The Breast 22 1001-53